Form 4 · EMR
Emerson President & CEO Surendralal Lanca Karsanbhai reports an award of 187,936 shares
Part of a grouped insider digest: see all related filings with totals →
Surendralal Lanca Karsanbhai, Emerson's President & CEO and a director, filed a Form 4 on Nov 4, 2026 at 4:42 PM ET reporting transactions between Nov 2, 2026 and Nov 3, 2026.
The filing reports 187,936 shares in a grant or award (code A); and 70,060 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists about 301,174 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Surendralal Lanca Karsanbhai's directly held shares by 64.3%, from about 183,298 to about 301,174.
Reporting person
- Surendralal Lanca Karsanbhai, President & CEO and a director (as filed: Karsanbhai Surendralal Lanca)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | A | Common Stock | 140,886 | Acquired | 324,184 | Direct | |
| 2026-11-02 | F | Common Stock | 62,061 | $167.95 | Disposed | 262,123 | Direct |
| 2026-11-02 | A | Common Stock | 47,050 | Acquired | 309,173 | Direct | |
| 2026-11-03 | F | Common Stock | 7,999 | $166.43 | Disposed | 301,174 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 4, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Emerson company file → · More Emerson filings
Disclosures
- Editor holdings in EMR
- The editor holds no position in Emerson (EMR). As of Nov 11, 2026.
- Last updated
- Nov 4, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold EMR.